IGC Pharma (IGC) Gains from Investment Securities (2010 - 2025)
IGC Pharma (IGC) reported Gains from Investment Securities of $25000.0 for Q1 2025, up 1150.0% year-over-year from $2000.0 in Q1 2024, and up 1150.0% quarter-over-quarter from $2000.0 in Q1 2024.
IGC Pharma (IGC) Gains from Investment Securities (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Gains from Investment Securities data on file, last reported at $25000.0 in Q1 2025.
- Gains from Investment Securities for Q1 2025 came in at $25000.0, up 1150.0% year-over-year; the trailing twelve-month figure through Mar 2025 was $197000.0 (up 428.33% YoY), and the FY2025 annual result was $25000.0, down 43.18% from the prior year.
- Gains from Investment Securities grew to $25000.0 in Q1 2025 per IGC's latest filing, from $2000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $170000.0 in Q4 2023 and troughed at -$2.0 million in Q1 2021.
- A 5-year average of -$270000.0 and a median of -$51500.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities plunged 488.89% in 2022, then surged 1150.0% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $27000.0 in 2021, then sank by 488.89% to -$105000.0 in 2022, then soared by 261.9% to $170000.0 in 2023, then slumped by 98.82% to $2000.0 in 2024, then surged by 1150.0% to $25000.0 in 2025.
- Business Quant data shows IGC's Gains from Investment Securities at $25000.0 in Q1 2025, $2000.0 in Q1 2024, and $170000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | IGC Pharma | 28.11 Mn | 27.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Mar 31, 2023 | -127,000.00 |
| Mar 31, 2023 | -127,000.00 |
| Dec 31, 2022 | -105,000.00 |
| Dec 31, 2022 | -105,000.00 |
| Mar 31, 2022 | -152,000.00 |
| Mar 31, 2022 | -152,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Mar 31, 2021 | -2.00 Mn |
| Mar 31, 2021 | -2.00 Mn |
| Dec 31, 2020 | -3.05 Mn |
| Dec 31, 2020 | -3.05 Mn |
| Sep 30, 2020 | -52,000.00 |
| Sep 30, 2020 | -52,000.00 |